Global Acne Medication Market Report and Forecast 2024-2032

Global Acne Medication Market Outlook

The global acne medication market reached a value of about USD 10.07 billion in 2023. The market for acne medication is being driven by the growing prevalence of acne disorders and the popularity of retinoids. The market is further expected to grow at a CAGR of 4.2% in the forecast period of 2024-2032 to attain nearly USD 14.59 billion by 2032.    

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Wide Range of Applications Driving the Acne Medication Industry Growth

Acne medication market expansion is being fuelled by an increase in the global prevalence of acne disorders. Teenagers' adoption of unhealthy lifestyles and the growing acceptance of skin care products are two key aspects driving the market growth. In addition, the availability and awareness of a wide range of products containing antibiotic agents, such as lotions, creams, and gels, as well as the additional benefits associated with their use, would boost the demand for acne medicine. Acne is becoming more common due to a variety of factors, including poor lifestyles, diets, smoking, hormonal changes, and excessive sebum secretion, among others. Furthermore, a dermatological survey found that the number of persons affected by acne is significant in westernised countries, including the North America region.

Acne Medication: Market Segmentation

Acne, also known as acne vulgaris, is a common skin disorder caused mostly by changes in skin structure. Millions of adolescents all over the world suffer from acne. Pimples, blackheads, greasy skin, and scarring are all symptoms. There are two types of acne, namely, non-inflammatory and inflammatory. Inflammatory acne takes longer to heal and can leave lasting scars on the skin. It usually affects areas of the body with a large number of sweat glands, such as the upper chest, back, and face. Acne medicines are pharmaceuticals that are used to treat acne.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on therapeutic class, the market is divided into:

• Retinoids
• Antibiotics
• Salicylic Acid
• Benzoyl Peroxide
• Others

On the basis of formulation, the market is categorised into:

• Topical Medications
• Oral Medications

The market is segmented based on type into:

• Prescription Medication
• Over-The-Counter Medication

By acne type, the market is bifurcated into:

• Non-Inflammatory Acne
• Inflammatory Acne

Based on distribution channel, the market is divided into:

• Retail Stores
• Pharmacies
• Online

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Demand for Retinoids to Aid the Growth of the Global Acne Medication Industry

There has been a rise in the popularity of retinoids to treat acne. Retinoids accounted for a significant share of the acne medication industry in 2020, owing to their great efficacy in treating moderate to severe acne and their ability to clear pores, allowing other treatments to work correctly. Acne's microcomedo–precursor lesion is the focus of topical retinoids. Based on the severity of acne, retinoids are typically used as a first-line treatment, either alone or in combination with other medicines. They are commonly used to treat severe inflammatory acne and are also a popular choice for maintenance therapy. Retinoids also diminish microcomedones and follicular obstruction in both non-inflammatory and inflammatory acne. These factors are expected to aid the industry growth in the forecast period.

Key Industry Players in the Global Acne Medication Market

The report gives a detailed analysis of the following key players in the global acne medication market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Almirall S.A
• Bausch Health Companies Inc.
• GlaxoSmithKline plc.
• Johnson & Johnson Services, Inc.
• Galderma S.A.
• Others 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report